Compression Garments in the Community with POTS
Summary
Postural Tachycardia Syndrome (POTS) is a disorder that features an inappropriate increase in heart rate upon standing in addition to chronic symptoms including lightheadedness, mental clouding, and palpitations. There are no medications specifically for POTS and individuals with POTS have varied treatment plans including a combination of medications and non-medication treatments.
One frequently prescribed treatment is compression garments. However, there is little evidence as to the effectiveness of these garments in the adults POTS population. This study will investigate the use of commercially available compression garments in the community in adults diagnosed with POTS. This study will not require in person attendance at the University of Calgary, and communication with the study team will be virtual.
Eligibility
Eligible ages: 18 to 60
Inclusion criteria:
1. Physician diagnosis of Postural Orthostatic Tachycardia Syndrome (POTS)
3. Own a waist high compression garment: medical grade or commercially available tights with a pressure rating provided (e.g. 15-18 mmHg, 20-30 mmHg, 30-40 mmHg) AND/OR owns an abdominal compression garment (e.g. abdominal shapewear, waist high shorts).
4. Able to participate in a 4-day study (2x2 day segments with a 5-day washout period)
Exclusion criteria:
1. Does not have a physician diagnosis of Postural Orthostatic Tachycardia Syndrome (POTS)
2. Does not own a waist high compression garment or abdominal compression garment
3. Individuals who are pregnant
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Ms. Kate Bourne PhD (Candidate)
Principal investigator:
Satish Raj
Clinical trial:
Yes
REB-ID:
REB20-2224